Related Experiment Video

Updated: Jul 10, 2026

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
06:29

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells

Published on: July 30, 2020

Aurora-A kinase regulates NF-kappaB activity: lessons from combination studies

Spiros Linardopoulos1

  • 1Breakthrough Breast Cancer Research Center, London, and Institute for Cancer Research, Sutton, UK. spiros.linardopoulos@icr.ac.uk

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|November 6, 2007
PubMed

Insights

Aurora-A kinase promotes cancer by activating NF-kappaB, leading to drug resistance. Inhibiting Aurora-A can enhance chemotherapy efficacy and overcome resistance in certain cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The Aurora-A/STK15 gene is amplified in various cancers, but its precise role and targets remain unclear.
  • Aurora-A kinase activity is linked to the degradation of IkappaBa, a key regulator of NF-kappaB.
  • NF-kappaB activation is associated with cancer development and resistance to chemotherapy.

Purpose of the Study:

  • To investigate the role of Aurora-A in NF-kappaB activation and its implications in human breast cancer.
  • To explore the association between NF-kappaB activity, cancer cell resistance, and the efficacy of chemotherapy.
  • To evaluate the therapeutic potential of inhibiting Aurora kinases in overcoming drug resistance.

Main Methods:

  • Analysis of Aurora-A gene amplification and NF-kappaB localization in primary human breast cancers.
  • Assessing NF-kappaB activity and chemoresistance in A549 lung and SKOV3 ovarian cancer cell lines.
  • Treatment of cancer cells with an Aurora kinase inhibitor and evaluation of NF-kappaB activity, drug sensitivity, and target gene expression.

Main Results:

  • Aurora-A gene amplification correlated with nuclear NF-kappaB localization in 13.6% of breast cancers.
  • High NF-kappaB activity in A549 and SKOV3 cells was linked to resistance to adriamycin and etoposide.
  • Inhibition of Aurora kinases downregulated NF-kappaB, enhanced cytotoxic drug efficacy, and reduced Bcl-XL/Bcl-2 expression.

Conclusions:

  • Aurora-A kinase promotes chemoresistance by activating the NF-kappaB pathway.
  • Inhibiting Aurora-A can sensitize cancer cells to chemotherapy and reverse acquired drug resistance.
  • Targeting Aurora-A represents a promising strategy to enhance cancer treatment efficacy, particularly in NF-kappaB-driven tumors.

More Related Videos

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...